Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Roundworm-Eating Fungus Has Cancer-Fighting Abilities

By LabMedica International staff writers
Posted on 17 Dec 2012
The fungus Arthrobotrys oligospora survives by eating roundworms, and a recent finding could give the fungus’s life more significance as a cancer fighter.

Dr. More...
Zhang, an associate professor of biomedical engineering at the University of Tennessee, Knoxville (USA) and coworkers, have discovered that nanoparticles generated by A. oligospora hold potential for stimulating the immune system and killing tumors. The findings are published in the December 2012 issue of the journal Advanced Functional Materials.

Dr. Zhang and research associate Dr. Yongzhong Wang were examining A oligospora’s trapping mechanisms for roundworms when they discovered the fungus secretes nanocomposites consisting of very uniform nanoparticles. Nanoparticles are miniscule particles that have been shown to be significant for cancer therapies.

“Naturally occurring nanoparticles have drawn increasing interest from scientific communities for their biocompatibility,” said Dr. Zhang. “Due to their high surface-to-volume ratio, nanoparticles have demonstrated unique optical, thermal, and electronic properties. In addition, their small size allows them to easily cross cell membranes, an essential requirement for cancer therapy.”

The researchers studied the fungal nanoparticles’ potential as a stimulant for the immune system, and found through an in vitro study that the nanoparticles activate secretion of an immune-system stimulant within a white blood cell line. They also assessed the nanoparticles’ possibilities as an antitumor agent by evaluating in vitro the toxicity to cells using two tumor cell lines, and discovered nanoparticles do kill cancer cells.

According to Dr. Zhang, nature faces many diseases, and offers rich mechanisms for curing them as a result of evolution. Nature-based nanostructures possess near endless diversity, which may offer novel solutions for therapeutic applications. “This study could be the entrance into a gold mine of new materials to treat cancers,” remarked Dr. Zhang. “Understanding how these nanostructures are formed in the natural systems will also provide templates for the synthesis of a future generation of engineered nanostructures for biomedical applications.”

The investigators approach has the potential to create a new way to control the generation of organic nanoparticles using synthetic biology. “This exciting discovery is the first step forward in the development of natural nanoparticle-based therapeutics for cancer treatment and demonstrates the importance of looking to nature for innovation in disease treatment,” concluded Dr. Zhang.

Related Links:

University of Tennessee, Knoxville




Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hematology Analyzer
Medonic M32B
Gold Member
Hybrid Pipette
SWITCH
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.